All members have the option of attending our various HTC-centric events which include:
Date: Wednesday, October 15th, 2025 Time: 2:00pm - 3:00pm ET WEBINAR TOPIC: Prophylaxis in VWD: Iron as a Metric of Success at Healing. WEBINAR SUMMARY: A presentation on rethinking prophylaxis in VWD through a lens of healing and iron status. This presentation explores a multidimensional approach to bleeding disorders, with a focus on Read the full article...
Date: Thursday, October 23rd, 2025 Time: 3:00pm - 4:00pm ET WEBINAR TITLE: Revolutionizing Hemophilia A Patient Care: Nurses’ Insights on the First Subcutaneous Prophylaxis Treatment for Hemophilia A. DESCRIPTION: Please join us for an engaging discussion featuring nurses Jennifer Maahs, RN, PNP, MSN and Joseph Stanco, MSN, DNP, CCRC as they share Read the full article...
Date: Thursday, October 30th, 2025 Time: 2:00pm - 3:00pm ET WEBINAR TOPIC: Alhemo (concizumab-mtci): A new option for patients living with hemophilia. OBJECTIVE: To provide an update on prescribing information of the recently FDA-approved indication in patients with hemophilia A or B without inhibitors, and supporting data from the explorer8 trial. AUDIENCE: Read the full article...
Date: Thursday, November 6th, 2025 Time: 1:00pm - 2:00pm ET WEBINAR TOPIC: Jivi — With Them as They Grow™ Clinical Study Data for Children 7 to 11 Years. OBJECTIVE: This session provides a clinical review of safety and efficacy data drawn from both the PROTECT Kids and Alfa-PROTECT studies. Data Read the full article...
Date: Wednesday, November 12th, 2025 Time: 1:00pm - 2:00pm ET WEBINAR TOPIC: VONVENDI® Approved for Adults and Pediatric Patients. OBJECTIVE: Understand the underlying mechanism of VWD and the role of VWF. Review unmet needs in the treatment of VWD. Identify the unique characteristics of VONVENDI as the first and only recombinant treatment Read the full article...
Date: Thursday, November 13th, 2025 Time: 1:00pm - 2:00pm ET WEBINAR TOPIC: The HEMGENIX Toolkit OBJECTIVE: Overview of the tools and resources available to treatment centers to help support patients eligible and interested in HEMGENIX AUDIENCE: All HTC Staff. SPEAKER: Bonnie Ben-Shmuel Bonnie Ben-Shmuel is a seasoned biopharmaceutical marketing leader with Read the full article...
Date: Wednesday, December 3rd, 2025 Time: 2:00pm - 3:00pm ET WEBINAR TOPIC: Translating Evidence into Practice: Real-World Patient Cases with ALTUVIIIO. OBJECTIVE: This session will bring together clinical evidence and real-world experience to illustrate how ALTUVIIIO can optimize treatment and improve outcomes for patients living with Hemophilia A. AUDIENCE: All HTC Staff. Read the full article...
Date: Thursday, December 11th, 2025 Time: 2:00pm - 3:00pm ET WEBINAR TITLE: New! Real-World Evidence to Support Optimization of Factor IX Prophylaxis SUMMARY: This webinar will discuss recent evidence on prophylactic treatment strategies for hemophilia B from a U.S. real-world retrospective analysis of factor IX products. The session will highlight factor Read the full article...
Date: January 11 - 13, 2026 Location: Newport Beach, CA Please contact Theresa Parker with any questions regarding this registration at theresa@hemoalliance.org or 727-688-2568.
Date: Thursday, January 15th, 2026 Time: 1:00pm - 2:00pm ET WEBINAR TITLE: Five-Year Analysis: Efficacy and Safety of HEMGENIX® SUMMARY: Presentation of the published efficacy and safety results of the five-year analysis of the HOPE-B clinical trial follow up. AUDIENCE: All HTC Staff. SPEAKER: Vidhi Desai, Senior Medical Director (Coagulation), US Read the full article...
Date: January 21 - 23, 2026 Location: Tampa, FL Please contact Theresa Parker with any questions regarding this application at theresa@hemoalliance.org or 727-688-2568.
Date: February 9 - 11 (San Diego, CA) Click here for info.
Date: February 25 - 27, 2026 Location: Oklahoma City, OK Please contact Theresa Parker with any questions regarding this registration at theresa@hemoalliance.org or 727-688-2568.
Date: March 4 - 6 (Washington, D.C.) Click here for info.
Date: Thursday, March 5th, 2026 Time: 1:00pm - 2:00pm ET WEBINAR TOPIC: Overview of Patient Tools & Support Resources. OBJECTIVE: This presentation will provide an overview of Takeda Hematology Patient tools and Support resources and education on the navigation of these tools and resources. AUDIENCE: All HTC Staff. SPEAKERS: Carley Riehle Read the full article...
Date: March 8 - 10, 2026 Location: Seattle, WA Please contact Theresa Parker with any questions regarding this registration at theresa@hemoalliance.org or 727-688-2568.
Date: Thursday, March 12th, 2026 Time: 1:00pm - 2:00pm ET WEBINAR TOPIC: Inhibitor Development in Hemophilia A: A Continuing Clinical Challenge Despite Therapeutic Advances. OBJECTIVE: After this webinar, participants will be able to: Describe the clinical impact and risk factors for FVIII inhibitor development in Previously Untreated Patients (PUPs) Summarize key Read the full article...
Date: March 19 - 21 (Portland, OR) Click here for info.
Date: Tuesday, March 31st, 2026 Time: 1:00pm - 2:00pm ET WEBINAR TOPIC: BrightStar Franchising, LLC Master Service Agreement for Nursing Services Now Available to Hemophilia Alliance Member Hemophilia Treatment Centers. OBJECTIVES: Understand the services of BrightStar Franchising, LLC. And what services are available to Hemophilia Alliance member HTCs under the Master Read the full article...
Date: April 9 - 12 (Las Vegas, NV) Click here for info.
